Tech Company Financing Transactions
Acylin Therapeutics Funding Round
On 6/30/2011, Acylin Therapeutics raised $2.4 million in funding from Allegis Capital, Amgen Ventures and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$2,399,900
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. 203
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Email Address
Not Recorded
Overview
Acylin Therapeutics is the first company focused on developing inhibitors of cellular acetylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and neurodegeneration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Suresh Jain
Browse more venture capital transactions:
Prev: 6/30/2011: Looxcie venture capital transaction
Next: 6/30/2011: Spectra Analysis venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs